TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 SEK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover | 6,610 | 6,107 | 4,855 |
Financial expenses | 0 | 354 | 5 |
Earnings before taxes | 4,589 | 3,782 | 3,347 |
EBITDA | 4,187 | 1,975 | 3,265 |
Total assets | 22,237 | 18,211 | 13,616 |
Current assets | 8,664 | 7,932 | 4,633 |
Current liabilities | 2,862 | 1,917 | 774 |
Equity capital | 19,045 | 15,366 | 12,031 |
- share capital | 50 | 50 | 50 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency | 85.6% | 84.4% | 88.4% |
Turnover per employee | 3,305 | 3,054 | 2,428 |
Profit as a percentage of turnover | 69.4% | 61.9% | 68.9% |
Return on assets (ROA) | 20.6% | 22.7% | 24.6% |
Current ratio | 302.7% | 413.8% | 598.6% |
Return on equity (ROE) | 24.1% | 24.6% | 27.8% |
Change turnover | 503 | 1,252 | 249 |
Change turnover % | 8% | 26% | 5% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.